Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-04

Clinical Trial Update: PSMA-Guided Ablation of the Prostate [Phase 2]

View source ↗

Summary

This ClinicalTrials.gov entry describes a Phase 2 study evaluating PSMA-guided ablation for localized prostate cancer. The trial is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University of Alberta | Conditions: Prostate Cancer, Localized Prostate Carcinoma | Phase 2 | Status: RECRUITING